COVIDcast - Tocilizumab [RECOVERY trial]
FOAMcast - An Emergency Medicine Podcast
English - February 13, 2021 14:48 - 12 minutes - 17.2 MB - ★★★★★ - 222 ratingsMedicine Health & Fitness Education Courses emergency covid covidcast foam foamed medicine Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Previous Episode: COVID Vaccine and Variants
Next Episode: COVIDcast - Colchicine in COVID-19
Early studies of tocilizumab, a monoclonal antibody that binds interleukin-6 , were disappointing. However, the REMAP-CAP trial recently reported a benefit to tocilizumab in non-critically ill hospitalized patients with COVID-19. Now, from the RECOVERY trial (the trial that brought us dexamethasone), we have more good news for tocilizumab - which we cover in this podcast
Show notes: FOAMcast.org
Thanks for listening!
Lauren Westafer and Jeremy Faust